These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19638618)

  • 1. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
    Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
    Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.
    Babel I; Barderas R; Diaz-Uriarte R; Moreno V; Suarez A; Fernandez-Aceñero MJ; Salazar R; Capellá G; Casal JI
    Mol Cell Proteomics; 2011 Mar; 10(3):M110.001784. PubMed ID: 21228115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
    PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays.
    Barderas R; Babel I; Díaz-Uriarte R; Moreno V; Suárez A; Bonilla F; Villar-Vázquez R; Capellá G; Casal JI
    J Proteomics; 2012 Aug; 75(15):4647-55. PubMed ID: 22465712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer.
    Niloofa R; De Zoysa MI; Seneviratne LS
    J Cancer Res Ther; 2021; 17(4):819-833. PubMed ID: 34528528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.
    Han SX; Wang J; Wang LJ; Jin GH; Ying X; He CC; Guo XJ; Zhang JY; Zhang Y; Zhu Q
    Tumour Biol; 2014 Jun; 35(6):6149-57. PubMed ID: 24652591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.
    Roessler M; Rollinger W; Mantovani-Endl L; Hagmann ML; Palme S; Berndt P; Engel AM; Pfeffer M; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
    Mol Cell Proteomics; 2006 Nov; 5(11):2092-101. PubMed ID: 16893879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of antibody and mRNA expression microarrays for identifying diagnostic and progression markers of early and late stage colorectal cancer.
    Spisák S; Galamb B; Sipos F; Galamb O; Wichmann B; Solymosi N; Nemes B; Molnár J; Tulassay Z; Molnár B
    Dis Markers; 2010; 28(1):1-14. PubMed ID: 20164542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips.
    Butvilovskaya VI; Popletaeva SB; Chechetkin VR; Zubtsova ZI; Tsybulskaya MV; Samokhina LO; Vinnitskii LI; Ragimov AA; Pozharitskaya EI; Grigor Eva GA; Meshalkina NY; Golysheva SV; Shilova NV; Bovin NV; Zasedatelev AS; Rubina AY
    Cancer Med; 2016 Jul; 5(7):1361-72. PubMed ID: 26992329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening.
    Pedersen JW; Gentry-Maharaj A; Nøstdal A; Fourkala EO; Dawnay A; Burnell M; Zaikin A; Burchell J; Papadimitriou JT; Clausen H; Jacobs I; Menon U; Wandall HH
    Int J Cancer; 2014 May; 134(9):2180-88. PubMed ID: 24122770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform.
    Garranzo-Asensio M; Guzmán-Aránguez A; Povedano E; Ruiz-Valdepeñas Montiel V; Poves C; Fernandez-Aceñero MJ; Montero-Calle A; Solís-Fernández G; Fernandez-Diez S; Camps J; Arenas M; Rodríguez-Tomàs E; Joven J; Sanchez-Martinez M; Rodriguez N; Dominguez G; Yáñez-Sedeño P; Pingarrón JM; Campuzano S; Barderas R
    Theranostics; 2020; 10(7):3022-3034. PubMed ID: 32194852
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray.
    Patwa TH; Li C; Poisson LM; Kim HY; Pal M; Ghosh D; Simeone DM; Lubman DM
    Electrophoresis; 2009 Jun; 30(12):2215-26. PubMed ID: 19582723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
    Chen H; Werner S; Tao S; Zörnig I; Brenner H
    Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-panel assay of serum autoantibodies in colorectal cancer.
    Ushigome M; Nabeya Y; Soda H; Takiguchi N; Kuwajima A; Tagawa M; Matsushita K; Koike J; Funahashi K; Shimada H
    Int J Clin Oncol; 2018 Oct; 23(5):917-923. PubMed ID: 29691673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer-A Preliminary Study.
    Pietrzyk Ł; Wdowiak P
    Cancer Control; 2020; 27(1):1073274820903351. PubMed ID: 32107922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.